CDSCO

21 May 2026

Injectable Cosmetics Not Allowed in India, Clarifies CDSCO

The Central Drugs Standard Control Organisation (CDSCO) has issued a public notice clarifying that cosmetic products cannot be used through injections and are not permitted for treatment purposes under Indian law.

The notice, released by the Directorate General of Health Services under the Ministry of Health and Family Welfare, comes amid rising use of aesthetic and beauty procedures in clinics and salons across the country.

2 May 2026

Chemistry or Biochemistry or Pharmacy candidates Requires in Central Drugs Testing Laboratory

Masters degree in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology from a recognized university or institute.

12 February 2026

CDSCO Approves AstraZeneca’s Imfinzi for Advanced Endometrial Cancer in India

AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India, to import and market Durvalumab Solution for Infusion 120 mg/2.4 mL and 500 mg/10 mL, sold under the brand name Imfinzi, for an additional indication in India.

5 February 2026

Career for Bench Chemist at Regional Drugs Testing Laboratory

B.Pharmacy with experience or M.Pharma, Master Degree in Chemistry / Microbiology. Candidates having experience in testing of drugs will be given preference. The candidates should also have sound knowledge of computer operation.

3 February 2026

Career opportunities with Central Drugs Testing Laboratory for Pharmacy candidates

Masters Degree in Pharmacology/ Physiology/ Veterinary Science/ Pharmacy/ Botany/ Chemistry/ Pharma Chemistry/ Biochemistry / Microbiology of a recognized University or equivalent.

28 January 2026

CDSCO eases Test Licence Pathway, cuts approval timelines under NDCT Rules Amendment 2026

In a move aimed at accelerating drug development while maintaining regulatory oversight, India’s drug regulator has notified sweeping changes to the New Drugs and Clinical Trials (NDCT) Rules, 2019, introducing a faster “prior intimation” route for select test licences and sharply reducing approval timelines.

The amendments, notified on January 20, 2026, under G.S.R. 46(E), mark a significant shift in how manufacturers can produce new drugs and investigational products for clinical trials, bioavailability, bioequivalence studies, and analytical testing

16 November 2025

Openings for Drugs Inspector (419 posts) under Ministry of Health and Family Welfare, recruitment rules

Bachelors degree in Pharmacy or Pharmaceutical Sciences or Medicine with specialisation in Clinical Pharmacology or Microbiology from a recognised University or institute.

17 September 2025

Advertisement for the post of Junior & Senior Scientific Assistant in CDTL

Masters degree in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology of a recognised university or institute.

22 August 2025

CDSCO alerted on theft of Novo Nordisk drug products during transit

Novo Nordisk has reported the theft of multiple batches of its critical injectable drug products during transit from its Bhiwandi Hub to destinations on the milk route covering Nagpur, Raipur, Cuttack, and Kolkata.

12 July 2025

Openings for Assistant Drugs Controller (22 posts) in CDSCO - Permanent Post

Master degree in Pharmacy or Pharmaceutical Sciences or Medicine with Clinical Pharmacology or Microbiology or Bio-Chemistry or Chemistry or Life Sciences. CDSCO Assistant Drugs Controller Medical Devices

Search

Injectable Cosmetics Not Allowed in India, Clarifies CDSCO

RECOMMENDED POSTS

Subscribe with us

Jobs by Category